6295-93-8 Usage
Description
2-(diphenylamino)-1H-isoindole-1,3(2H)-dione is a complex chemical compound derived from isoindole-1,3-dione, featuring a nitrogen-containing heterocyclic structure. Characterized by the presence of two phenyl groups attached to an amino group, this versatile molecule exhibits unique properties that make it valuable in various applications.
Uses
Used in Dye and Ink Manufacturing:
2-(diphenylamino)-1H-isoindole-1,3(2H)-dione is utilized as a pigment in the production of dyes and inks, capitalizing on its color-producing properties to create a wide range of hues for various industries.
Used in Organic Synthesis and Materials Science:
In the realm of organic synthesis and materials science, 2-(diphenylamino)-1H-isoindole-1,3(2H)-dione is employed as a building block for the development of new materials and compounds, leveraging its unique structural and chemical characteristics.
Used in Medical Applications:
2-(diphenylamino)-1H-isoindole-1,3(2H)-dione has potential applications in the medical field, where it is explored for its ability to inhibit specific enzymes and biological processes, offering a promising avenue for the development of new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 6295-93-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,2,9 and 5 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 6295-93:
(6*6)+(5*2)+(4*9)+(3*5)+(2*9)+(1*3)=118
118 % 10 = 8
So 6295-93-8 is a valid CAS Registry Number.
6295-93-8Relevant articles and documents
INHIBITORS OF IRES-MEDIATED PROTEIN SYNTHESIS
-
Page/Page column 38; 43, (2017/12/18)
This disclosure relates to inhibitors of IRES-mediated protein synthesis, compositions comprising therapeutically effective amounts of these compounds, and methods of using those compounds and compositions in treating hyperproliferative disorders, e.g., cancers. This disclosure also relates to compositions comprising inhibitors of IRES-mediated protein synthesis and mTOR inhibitors, and to methods of treating cancer by conjoint administration of inhibitors of IRES-mediated protein synthesis and mTOR inhibitors.
Synthesis of hole-transporting hydrazone dendrimers
Nam, Haehyun,Kang, Dae Ho,Kim, Jai Kyeong,Park, Soo Young
, p. 1298 - 1299 (2007/10/03)
Hole-transporting aromatic hydrazone dendrimers were synthesized by convergent method. Structures of dendrimers were characterized by NMR, IR, GC/MS (FAB+), and elemental analysis.
